Evidence map›Paper›PMID 32014033›Full record

ArticleTrials2020

Statistical analysis plan for the randomized controlled trial CardioCare MV investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease.

Andreas Ziegler, Miriam Mann, Bernard Brandewiede, Hermann Dittrich, Sissy Hintz, Katja Krockenberger, Alper Öner, Marcos Oliviera de Sousa, Christian Schmidt

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03317951 (A Randomized Controlled Trial for Investigating a Novel Integrated Care Concept), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03317951 naunknown statusnot on this map

A Randomized Controlled Trial for Investigating a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease: CardioCare MV

TypeinterventionalSponsorUniversity Medical Center RostockRan2017 to 2020Enrolled964ConditionsHeart Failure, Atrial Fibrillation, Treatment Resistant HypertensionArmsNovel integrated care concept (NICC), Standard care
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreas ZieglerStatSol, Moenring 2, 23560, Lübeck, Germany. andreas.ziegler@medizincampus-davos.ch.ORCID http://orcid.org/0000-0002-8386-5397
Miriam MannUniversitätsmedizin Rostock Versorgungsstrukturen GmbH, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany. miriam.mann@umr-v.de.
Bernard BrandewiedeAMEDON GmbH, Willy-Brand-Allee 31c, 23554, Lübeck, Germany.
Hermann DittrichUniversitätsmedizin Rostock Versorgungsstrukturen GmbH, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany.
Sissy HintzUniversitätsmedizin Rostock Versorgungsstrukturen GmbH, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany.
Katja KrockenbergerAMEDON GmbH, Willy-Brand-Allee 31c, 23554, Lübeck, Germany.
Alper ÖnerAbteilung Kardiologie, Universitätsmedizin Rostock, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany.
Marcos Oliviera de SousaUniversitätsmedizin Rostock Versorgungsstrukturen GmbH, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany.
Christian SchmidtUniversitätsmedizin Rostock, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany.

Funding

Gemeinsamer Bundesausschuss 01NVF16003
6 · The paper itself

Abstract

backgroundCardiovascular diseases are the major cause of death globally and represent a major economic burden on health care systems. For patients with heart failure, atrial fibrillation or therapy-resistant hypertension, we have developed a novel integrated care concept (NICC) which combines telemedicine with intensive support by a care center, including a call center, an integrated care network including inpatient and outpatient care providers and guideline therapy for patients (Schmidt et al. 2018 Trials 19:120). Here, we describe challenges and solutions in patient recruitment and provide the statistical analysis plan.

methodsThe study CardioCare MV is a prospective, randomized, controlled, parallel-group, open-label, bi-center trial with two groups for comparing NICC with standard of care (SoC). Because of issues with patient enrollment we adapted the study plan after consultation with the Ethics Committee and the funding agency. We altered the analysis strategy for the primary endpoints, which led to a change in the required sample size. We also changed the access points to patients from inpatient hospitals specialized in the treatment of patients with cardiovascular disease to specialized practices.

resultsRecruitment of patients started on 1 December 2017, and first patient in was on 4 December 2017. Recruitment was completed on 15 August 2019 as planned according to the amended study plan. The follow-up period will end in August 2020. A total of 964 patients was enrolled into the trial. The statistical analysis plan was finalized prior to last patient in. Results will be available by the end of 2020. DISCUSSION: The trial will inform care providers whether quality of care can be improved by an integrated care concept providing telemedicine through a round-the-clock call center approach. We expect that cost of the NICC will be lower than standard care because of reduced hospitalizations. The trial will guide additional research to disentangle the effects of this complex intervention.

trial registrationDRKS, ID: DRKS00013124. Registered on 5 October 2017 ClinicalTrials.gov, ID: NCT03317951. Registered on 17 October 2017.

Indexed as

Patient SelectionAtrial FibrillationChronic DiseaseDelivery of Health Care, IntegratedFollow-Up StudiesHeart FailureHumansHypertensionLength of StayMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as TopicStandard of CareTelemedicineAtrial fibrillationCare centerDisease management programEvidence-based careHeart failureHospitalizationIntegrated careRandomized controlled trialTelemedicineTreatment-resistant hypertension

Identifiers

PMID32014033
PMCPMC6998105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.